Screener
Avalo Therapeutics AVTX Business Segments — CMC expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Avalo Therapeutics in its filing.
Tagged under the XBRL concept avtx:ChemistryManufacturingAndControlExpenses.
The source filing: Avalo Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001534120-26-000049
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Nonclinical expenses | $249 | $179 | $640 | $262 |
| Clinical expenses | 3,712 | 7,215 | 9,344 | 11,065 |
| CMC expenses | 5,068 | 3,266 | 9,194 | 5,245 |
| License and milestone expenses | 10,000 | — | 10,000 | — |
| Internal expenses: | ||||
| Salaries, benefits and related costs | 2,630 | 2,181 | 5,216 | 4,030 |
| Stock-based compensation expense | 1,680 | 1,116 | 2,923 | 2,418 |
| Other | 79 | 117 | 149 | 175 |
Item 1. Financial Statements.
FAQ
- What is Avalo Therapeutics's business segments — CMC expenses?
- Avalo Therapeutics (AVTX) reported business segments — CMC expenses of $5.07M in Q2 2026.
- How has Avalo Therapeutics's business segments — CMC expenses changed year-over-year?
- Avalo Therapeutics's business segments — CMC expenses increased by 55.2% year-over-year, from $3.27M to $5.07M.
- What is the long-term trend for Avalo Therapeutics's business segments — CMC expenses?
- Over 2 years (2023 to 2025), Avalo Therapeutics's business segments — CMC expenses has grown at a 128.2% compound annual growth rate (CAGR), from $1.86M to $9.66M.
- What does business segments — CMC expenses mean?
- Covers Chemistry, Manufacturing, and Controls (CMC) activities required to develop and scale the manufacturing processes for drug candidates. These costs ensure that the drug product is produced consistently and meets quality standards for clinical trials and commercial supply. Effective management of CMC expenses is essential for transitioning from research to scalable drug production.
Ask your AI about Avalo Therapeutics's business segments — cmc expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude